Cardiology

  • In Reply: Trousseau sign and syndrome: Erroneous terms
    Satish S. Maharaj, MD, Michael Omar, MBBS, Karan Seegobin, MBBS and Simone Chang, MBBS
    Cleveland Clinic Journal of Medicine October 2020, 87 (10) 586; DOI: https://doi.org/10.3949/ccjm.87c.10003

    Trousseau sign should continue to be taught and recognized on physical examination.

  • Should we give triple therapy to patients with atrial fibrillation after percutaneous intervention?
    Asim Kichloo, MD, Michael M. Aljadah, MD, Farah Wani, MD and Sindhura Ananthaneni, MD
    Cleveland Clinic Journal of Medicine October 2020, 87 (10) 599-601; DOI: https://doi.org/10.3949/ccjm.87a.19115

    Triple therapy is aggressive and carries high risks of bleeding and death.

  • Peripheral artery disease and unusual skin findings
    Aaron Andrew Heigaard Smith, MD, Erin Luxenberg, MD and Roberta Meyers, MD, MPH
    Cleveland Clinic Journal of Medicine October 2020, 87 (10) 605-612; DOI: https://doi.org/10.3949/ccjm.87a.19074

    A 68-year-old man was admitted because of worsening skin problems in his legs.

  • SARS-CoV-2 and myocardial injury: Few answers, many questions
    SARS-CoV-2 and myocardial injury: Few answers, many questions
    Paul C. Cremer, MD
    Cleveland Clinic Journal of Medicine September 2020, 87 (9) 521-525; DOI: https://doi.org/10.3949/ccjm.87a.ccc001

    What is the mechanism? Is this a distinct population? What are the treatment options?

  • Thoracic aortic aneurysm: Optimal surveillance and treatment
    CME article
    Tom Kai Ming Wang, MBCHB, MD(res), FRACP and Milind Y. Desai, MD
    Cleveland Clinic Journal of Medicine September 2020, 87 (9) 557-568; DOI: https://doi.org/10.3949/ccjm.87a.19140-1

    Early detection, surveillance, and treatment are critical.

  • In Reply: Aspirin for primary prevention
    Aldo L. Schenone, MD and A. Michael Lincoff, MD
    Cleveland Clinic Journal of Medicine August 2020, 87 (8) 458-459; DOI: https://doi.org/10.3949/ccjm.87c.08006
  • Aspirin for primary prevention
    Elise Henning, MD, MEd
    Cleveland Clinic Journal of Medicine August 2020, 87 (8) 458; DOI: https://doi.org/10.3949/ccjm.87c.08005
  • Should we monitor troponin up to peak value when evaluating for acute coronary syndrome?
    Nolan Anderson, MD, Samuel T. Ives, MD, Michelle D. Carlson, MD and Fred Apple, PhD, DABCC
    Cleveland Clinic Journal of Medicine August 2020, 87 (8) 480-482; DOI: https://doi.org/10.3949/ccjm.87a.18125

    No. Once troponin is over the 99th percentile, finding the peak value does not aid in diagnosis.

  • Cardiac troponin testing: Goodbye, ‘troponinemia’
    Anirudh Kumar, MD, Divyang R. Patel, MD and Venugopal Menon, MD
    Cleveland Clinic Journal of Medicine August 2020, 87 (8) 483-484; DOI: https://doi.org/10.3949/ccjm.87a.20013

    Any troponin elevation is prognostically important; dismissing it as “troponinemia” is no longer a viable strategy.

  • Does a short QT interval increase the risk of cardiac death in healthy people?
    Ahmed Subahi, MD, Ahmed S. Yassin, MD, Oluwole Adegbala, MD, Mohamed Shokr, MD and Luis Afonso, MD
    Cleveland Clinic Journal of Medicine July 2020, 87 (7) 398-400; DOI: https://doi.org/10.3949/ccjm.87a.19090

    No, but it may warrant further investigation to determine if the patient is at risk.

Pages